d-limonene suppresses doxorubicin-induced oxidative stress and inflammation via repression of COX-2, iNOS, and NFκB in kidneys of Wistar rats

Experimental Biology and Medicine

Volumn 239, Issue 4, 2014, Pages 465-476

  Rehman, Muneeb U ^a   Tahir, Mir ^a   Khan, Abdul Quaiyoom ^a   Khan, Rehan ^a   Oday O Hamiza, ^a   Lateef, Abdul ^a   Hassan, Syed Kazim ^a   Rashid, Sumaya ^a   Ali, Nemat ^a   Zeeshan, Mirza ^a   Sultana, Sarwat ^a  

^a HAMDARD UNIVERSITY   (India)

Author keywords

Chemoprevention; d limonene; doxorubicin; nephrotoxicity

Indexed keywords

CHEMOPREVENTION; D-LIMONENE; DOXORUBICIN; NEPHROTOXICITY;

ANIMALS; ANTIOXIDANTS; BIOLOGICAL MARKERS; CYCLOHEXENES; CYCLOOXYGENASE 2; CYTOKINES; DOXORUBICIN; GLUTATHIONE; KIDNEY; LIPID PEROXIDATION; NF-KAPPA B; NITRIC OXIDE SYNTHASE TYPE II; NITRITES; OXIDATIVE STRESS; PROTECTIVE AGENTS; RATS; RATS, WISTAR; TERPENES;

EID: 84898956949     PISSN: 15353702     EISSN: 15353699     Source Type: Journal    
DOI: 10.1177/1535370213520112     Document Type: Article

References (60)

1. Chen Y,Jungsuwadee P,Vore M,Butterfield DA,Clair DK.Collateral damage in cancer chemotherapy: oxidative stress in non targeted tissues.Mol Interv. 2007;7:147-56.
2. Handa K,Sato S.Generation of free radicals of quinone group-containing anticancer chemicals in NADPH-microsome system as evidenced by initiation of sulfite oxidation.Gann. 1975;66:43-7.
3. Gutteridge JM.Lipid peroxidation and possible hydroxyl radical formation stimulated by the self-reduction of a doxorubicin-iron(III) complex.Biochem Pharmacol. 1984;33:1725-8.
4. Saad SY,Najjar TA,Al-Rýkaby AC.The preventive role of deferoxamine against acute doxorubicin-induced cardiac, renal and hepatic toxicity in rats.Pharmacol Res. 2011;43:211-8.
5. Pritsos CA,Ma J.Basal and drug-induced antioxidant enzyme activities correlate with age-dependent doxorubicin oxidative toxicity.Chem Biol Interact. 2000;127:1-11.
6. Fadillioglu E,Erdogan H.Effects of erdosteine treatment against doxorubicin-induced toxicity through erythrocyte and plasma oxidant/antioxidant status in rats.Pharmacol Res. 2003;47:317-22.
7. Ghosh J,Das J,Manna P,Sil PC.The protective role of arjunolic acid against doxorubicin induced intracellular ROS dependent JNK-p38 and p53-mediated cardiac apoptosis.Biomaterials. 2011;32:4857-66.
8. Mosser DM,Zhang X.Interleukin-10: new perspectives on an old cytokine.Immunol Rev. 2008;226:205-18.
9. Mohamed RH,Karamb RA,Amerc MG.Epicatechin attenuates doxorubicin-induced brain toxicity: critical role of TNF-α, iNOS and NF-κB.Brain Res Bull. 2011;86:22-8.
10. Uchida Y,Itoh M,Taguchi Y,Yamaoka S,Umehara H,Ichikawa S,Hirabayashi Y,Holleran WM,Okazaki T.Ceramide reduction and transcriptional up-regulation of glucosylceramide synthase through doxorubicin-activated Sp1 in drug-resistant HL-60/ADR cells.Cancer Res. 2004;1 (64): 6271-9.
11. Aluise CD,Miriyala S,Noel T,Sultana R,Jungsuwadee P,Taylor TJ,Cai J,Pierce WM,Vore M,Moscow JA,St Clair DK.Butterfield DA 2-Mercaptoethane sulfonate prevents doxorubicin-induced plasma protein oxidation and TNF-α release: implications for the reactive oxygen species-mediated mechanisms of chemobrain.Free Radic Biol Med. 2011;50:1630-8.
12. Arjumand W,Seth A,Sultana S.Rutin attenuates cisplatin induced renal inflammation and apoptosis by reducing NFκB, TNF-α and caspase-3 expression in wistar rats.Food Chem Toxicol. 2011;49:2013-21.
13. Rashid S,Ali N,Nafees S,Ahmad ST,Arjumand W,Hasan SK,Sultana S.Alleviation of doxorubicin-induced nephrotoxicity and hepatotoxicity by chrysin in Wistar rats.Toxicol Mech Methods. 2013;23:337-45.
14. Christopher DA,Miriyala S,Noel T,Sultana R,Jungsuwadee P,Taylor TJ,Cai J,Pierce WM,Vore M,Moscow JA,Clair DK,St, Butterfield DA.2-Mercaptoethane sulfonate prevents doxorubicin-induced plasma protein oxidation and TNF-α release: Implications for the reactive oxygen species-mediated mechanisms of chemobrain.Free Radic Biol Med. 2011;50:1630-8.
15. Adderley SR,Fitzgerald DJ.Oxidative damage of cardiomyocytes is limited by extracellular regulated kinases 1/2-mediated induction of cyclooxygenase-2.J Biol Chem. 1999;274:5038-46.
16. Singletery K.Diet, natural products and cancer chemoprevention.J Nutr. 2000;130:465-6.
17. Patel N,Joseph C,Corcoran GB,Ray SD.Silymarin modulates doxorubicin-induced oxidative stress, Bcl-xL and p53 expression while preventing apoptotic and necrotic cell death in the liver.Toxicol Appl Pharmacol. 2010;245:143-52.
18. Yilmaz S,Atessahin A,Sahna E,Karahan I,Ozer S.Protective effect of lycopene on adriamycin-induced nephrotoxicity and nephrotoxicity.Toxicology. 2006;218:164-71.
19. Ajith TA,Aswathy MS,Hema U.Protective effect of Zingiber officinale roscoe against anticancer drug doxorubicin-induced acute nephrotoxicity.Food Chem Toxicol. 2008;46:3178-3181.
20. Mohan M,Kamble S,Gadhi P,Kasture S.Protective effect of Solanum torvum on doxorubicin-induced nephrotoxicity in rats.Food Chem Toxicol. 2010;48:436-40.
21. Oktem G,Uysal A,Oral O,Sezer ED,Olukman M,Erol A,Akgur SA,Bilir A.Resveratrol attenuates doxorubicin-induced cellular damage by modulating nitric oxide and apoptosis.Exp Toxicol Pathol. 2012;64:471-9.
22. Kesterson JW, Hendrickson R, Braddock RJ. Florida citrus oils. Technical Bulletin 749. Gainesville, FL. University of Florida Institute of Food and Agricultural Sciences, 1971; 3-74.
23. Zhao C,Zeng Y,Wan M,Li R,Liang Y,Li C,Zeng Z,Chau FT.Comparative analysis of essential oils from eight herbal medicines with pungent flavor and cool nature by GC-MS and chemometric resolution methods.J Sep Sci. 2009;32:660-70.
24. Crowell PL,Elson CE,Bailey HH,Elegbede A,Haag JD,Gould MN.Human metabolism of the experimental cancer therapeutic agent d-limonene.Cancer Chemother Pharmacol. 1994;35:31-7.
25. Vigushin DM,Poon GK,Boddy A,English J,Halbert GW,Pagonis C,Jarman M,Coombes RC.Phase I and pharmacokinetic study of d-limonene in patients with advanced cancer. Cancer Research Campaign Phase I/II Clinical Trials Committee.Cancer Chemother Pharmacol. 1998;42:111-7.
26. Antunes LMG,Takahashi CS.Olive oil protects against chromosomal aberrations induced by doxorubicin in Wistar rat bone marrow cells.Genet Mol Biol. 1999;2:225-7.
27. Sahna E,Parlakpinar H,Ozer MK,Ozturk F,Ozugurlu F,Acet A.Melatonin protects against myocardial doxorubicin toxicity in rats: role of physiological concentrations.J Pineal Res. 2003;35:257-61.
28. Benguedouar L,Boussenane NH,Kebsa W,Alyane M,Rouibah H,Lahouel M.Efficacy of propolis extract against mitochondrial stress induced by antineoplastic agents (doxorubicin and Vinblastin) in rats.Ind J Exp Biol. 2008;46:112-9.
29. Alves dos Santosa R,Jordão AA,Vannucchi H,Takahashi CS.Protection of doxorubicin-induced DNA damage by sodium selenite and selenomethionine in Wistar rats.Nutr Res. 2007;27:343-8.
30. Claiborne ACRC handbook of methods in oxygen radical research. Greenwald RA, ed. Boca Raton, FL: CRC Press; 1985:283-4.
31. Habig WH,Pabst MJ,Jakoby WB.Glutathione-S-transferases: the first enzymatic step in mercapturic acid formation.J Biol Chem. 1974;249:7130-9.
32. Jollow DJ,Mitchell JR,Zampaglione N,Gillette JR.Bromobenzene induced liver necrosis: protective role of glutathione and evidence for 3,4-bromobezene oxide as the hepatotoxic metabolite.Pharmacology. 1974;11:151-151.
33. Mohandas M,Marshall JJ,Duggin GG,Horvath JS,Tiller D.Differential distribution of glutathione and glutathione related enzymes in rabbit kidney.Cancer Res. 1984;44:5086-91.
34. Stripe F,Della Corte E.The regulation of rat liver xanthine oxidase.J Biol Chem. 1969;244:3855-63.
35. Marklund S,Marklund G.Involvement of the superoxide anion radical in the autoxidation of pyrogallol and a convenient assay for superoxide dismutase.Eur J Biochem. 1974;47:469-74.
36. Wright JR,Colby HD,Miles PR.Cytosolic factors which affect microsomal lipid peroxidation in lung and liver.Arch Biochem Biophys. 1981;206:296-304.
37. Carlberg I,Mannervik B.Glutathione level in rat brain.J Biol Chem. 1975;250:4480-4575.
38. Benson AM,Hunkalar MJ,Talalay P.Increase of NADPH, quinone reductase activity by dietary antioxidant: possible role in protection against carcinogenesis and toxicity.Proc Natl Acad Sci USA. 1980;77:5116-220.
39. Kornberg AMethods in enzymology. Colowick SPKaplan NO, ed. New York: Academic Press; 1955:441-3.
40. Green LC,Wagner DA,Glogowski J,Skipper PL,Wishnok JS,Tannenbaum SR.Analysis of nitrate, nitrite, and [15N] nitrate in biological fluids.Anal Biochem. 1982;126:131-8.
41. Pick A,Keisari Y.Superoxide anion and H2O2 production by chemically elicited peritoneal macrophages-induction by multiple non-phagocytic stimulus.Cell Immunol. 1981;59:301-8.
42. Lowry OH,Rosebrough NJ,Farr A,Randall RJ.Protein measurement with the Folin phenol reagent.J Biol Chem. 1951;193:265-75.
43. Injac R.Boskovic M, Perse M, Koprivec-Furlan E, Cerar A, Djordjevic A, Strukelj B. Acute doxorubicin nephrotoxicity in rats with malignant neoplasmcan be successfully treated with fullerenol C60(OH)24 via suppression of oxidative stress.Pharmacol Rep. 2008;60:742-9.
44. Singal PK,Li T,Kumar D,Danelisen I,Hiskovic N.Adriamycin-induced heart failure: mechanism and modulation.Mol Cell Biochem. 2000;207:77-86.
45. De Beer EL,Bottone AE,Voest EE.Doxorubicin and mechanical performance of cardiac trabeculae after acute and chronic treatment: a review.Eur J Pharmacol. 2001;415:1-11.
46. Maróstica MR,Rocha e Silvac TAA,Franchi GC,Nowill A,Pastorea GM,Hyslop S.Antioxidant potential of aroma compounds obtained by limonene biotransformation of orange essential oil.Food Chem. 2009;116:8-12.
47. Ogunbayode I,Ishola IO,Olufunsho A.Protective role of ascorbic acid and alpha tocopherol against acetaminophen-induced nephrotoxicity in rats.Afr J Pharma Sci Pharmacy. 2010;1:96-111.
48. Bou Matar RN,Klein JD,Sands JM.Erlotinib preserves renal function and prevents salt retention in doxorubicin treated nephrotic rats.PLoS One. 2013;8:e54738.-e54738.
49. Zhou Y,Vaidya VS,Brown RP,Zhang J,Rosenzweig BA,Thompson KL,Miller TJ,Bonventre JV,Goering PL.Comparison of kidney injury molecule-1 and other nephrotoxicity biomarkers in urine and kidney following acute exposure to gentamicin, mercury, and chromium.Toxicol Sci. 2008;101:159-159.
50. Rehman MU,Tahir M,Khan AQ,Khan R,Lateef A,Oday-O-Hamiza,Qamar W,Ali F,Sultana S.Chrysin suppresses renal carcinogenesis via amelioration of hyperproliferation, oxidative stress and inflammation: plausible role of NF-κB.Toxicol Lett. 2013;216:146-58.
51. Deepa PR,Varalakshmi P.Influence of a low-molecular-weight heparin derivative on the nitric oxide levels and apoptotic DNA damage in adriamycin-induced cardiac and renal toxicity.Toxicology. 2006;217:176-83.
52. Frangogiannis NG.The immune system and cardiac repair.Pharmacol Res. 2008;58:88-111.
53. Irmak MK,Fadillioglu E,Sogut S,Erdogan H,Gulec M,Ozer M,Yagmurca M,Gozukara ME.Effects of caffeic acid phenethyl ester and alphatocopherol on reperfusion injury in rat brain.Cell Biochem Funct. 2003;26:783-7.
54. Pacher P,Liaudet L,Bai P,Mabley JG,Kaminski PM,Virág L,Deb A,Szabó E,Ungvári Z,Wolin MS,Groves JT,Szabó C.Potent metalloporphyrin peroxynitrite decomposition catalyst protects against the development of doxorubicin-induced cardiac dysfunction.Circulation. 2003;107:896-904.
55. Sayed-Ahmed MM,Khattab MM,Gad MZ,Osman AM.Increased plasma endothelin-1 and cardiac nitric oxide during doxorubicin-induced cardiomyopathy.Pharmacol Toxicol. 2001;89:140-4.
56. Akama KT,Van Eldik LJ.Beta-amyloid stimulation of inducible nitric-oxide synthase in astrocytes is interleukin-1beta and tumor necrosis factor-alpha (TNFalpha)-dependent, and involves a TNFalpha receptor-associated factor and NF kappa inducing kinase-dependent signaling mechanism.J Biol Chem. 2000;275:7918-24.
57. Santoro MG,Rossi A,Amici C.NF-kappaB and virus infection: who controls whom?.EMBO J. 2003;22:2552-60.
58. Snyder AR,Morgan WF.Differential induction and activation of NF-kappaB transcription complexes in radiation-induced chromosomally unstable cell lines.Environ Mol Mutagen. 2005;45:177-187.
59. Sun J.d-limonene: safety and clinical applications.Alt Med Rev. 2007;12:2007-2007.
60. Kim YW,Kim MJ,Chung BY,Bang du Y,Lim SK,Choi SM,Lim DS,Cho MC,Yoon K,Kim HS,Kim KB,Kim YS,Kwack SJ,Lee BM.Safety evaluation and risk assessment of d-limonene.J Toxicol Environ Health B Crit Rev. 2013;16:17-38.